InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Prentiss Christopher B, Chief Financial Officer. Officer active across 1 companies, notably Adamas Pharmaceuticals Inc. In total, 2 reports have been published. The latest transaction was disclosed on 24 November 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
018,750 shares0
Common Stock
SEC:0001328143-21-000092·
018,750 shares0
Common Stock
SEC:0001328143-21-000092:0·
2 of 2 declarations
About Prentiss Christopher B
Christopher B. Prentiss is the Chief Financial Officer of Adamas Pharmaceuticals Inc. He oversees the company's financial operations, including budgeting and risk management. Adamas Pharmaceuticals focuses on developing treatments for neurological diseases. Christopher's expertise in finance is essential to ensure the company's financial health.
